We are live on ! Find out more
CMPX icon

Compass Therapeutics
CMPX

76 hedge funds and large institutions have $177M invested in Compass Therapeutics in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 30 increasing their positions, 19 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

58% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 19

4% more funds holding

Funds holding: 73 → 76 (+3)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

1.13% less ownership

Funds ownership: 71.52% → 70.39% (-1.1%)

39% less capital invested

Capital invested by funds: $288M → $177M (-$111M)

Holders
76
Holders Change
+3
Holders Change %
+4.11%
% of All Funds
1.21%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
8
Increased
30
Reduced
19
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$1.09M
2
Blackstone Inc
Blackstone Inc
New York
+$467K
3
Millennium Management
Millennium Management
New York
+$354K
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$321K
5
Goldman Sachs
Goldman Sachs
New York
+$278K

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.43M
2
MIM
Monashee Investment Management
Massachusetts
-$1.84M
3
PM
Prosight Management
Texas
-$368K
4
LP
LMR Partners
United Kingdom
-$257K
5
FCMV
Foresite Capital Management V
California
-$191K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$44.1M – – –
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$13.1M +$1.09M +441,897 +7%
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$12.6M +$321K +130,000 +2%
Blackstone Inc
4
Blackstone Inc
New York
$12.2M +$467K +188,811 +3%
BlackRock
5
BlackRock
New York
$11.8M -$145K -58,557 -1%
B
6
Braidwell
Connecticut
$11.7M – – –
RSCM
7
Rock Springs Capital Management
Maryland
$10.9M – – –
Fidelity Investments
8
Fidelity Investments
Massachusetts
$8.97M -$2.43M -982,413 -18%
Vanguard Group
9
Vanguard Group
Pennsylvania
$8.09M +$23.8K +9,637 +0.2%
VC
10
Vivo Capital
California
$7.01M – – –
CA
11
CHI Advisors
New York
$5.57M – – –
Geode Capital Management
12
Geode Capital Management
Massachusetts
$3.73M +$208K +84,114 +5%
State Street
13
State Street
Massachusetts
$3.46M +$23.7K +9,599 +0.5%
APM
14
Avidity Partners Management
Texas
$3.15M -$50.9K -20,600 -1%
BBA
15
Baker Bros. Advisors
New York
$3.07M – – –
FCMV
16
Foresite Capital Management V
California
$2.46M -$191K -77,094 -6%
MIM
17
Monashee Investment Management
Massachusetts
$2.42M -$1.84M -743,154 -38%
PM
18
Prosight Management
Texas
$1.84M -$368K -148,840 -14%
ABG
19
Ally Bridge Group
New York
$1.8M – – –
Northern Trust
20
Northern Trust
Illinois
$1.63M +$137K +55,249 +7%
N
21
Nuveen
North Carolina
$783K +$14K +5,663 +1%
Millennium Management
22
Millennium Management
New York
$604K +$354K +143,157 +88%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$537K +$2.86K +1,156 +0.4%
Charles Schwab
24
Charles Schwab
California
$519K +$29.4K +11,880 +5%
Goldman Sachs
25
Goldman Sachs
New York
$434K +$278K +112,626 +105%
1
2 3 4

CMPX Hedge Fund Activity: Q3 2023 in Review

76 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Compass Therapeutics (CMPX) for Q3 2023, worth a combined $177M — down 39% from $288M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new CMPX positions and 5 closed out — a net gain of 3 holders — while 30 added to existing stakes and 19 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $1.09M. The largest seller was Fidelity Investments, cutting an estimated $2.43M.

  • 76 institutional investors held Compass Therapeutics (CMPX) as of Q3 2023, up from 73 in Q2 2023.
  • Funds reported $177M of Compass Therapeutics stock for Q3 2023, down 39% quarter-over-quarter.
  • 8 funds opened new Compass Therapeutics positions in Q3 2023 and 5 closed out, a net change of +3 holders.
  • The largest Compass Therapeutics buyer in Q3 2023 was Janus Henderson Group, an estimated $1.09M added.
  • The largest Compass Therapeutics seller in Q3 2023 was Fidelity Investments, an estimated $2.43M sold.

Based on aggregated 13F filings for Q3 2023.